MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-14-2025
Utah Medical Products Operating Cash Flow 2011-2026 | UTMD
Annual Operating Cash Flow Utah Medical Products
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22.3 M | 21.1 M | 21.2 M | 20.1 M | 17.1 M | 16.8 M | 16.9 M | 14.5 M | 13.8 M | 15.4 M | 12.3 M | 13.6 M | 11.4 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 22.3 M | 11.4 M | 16.7 M |
Quarterly Operating Cash Flow Utah Medical Products
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 4.46 M | - | - | - | 5.28 M | - | - | - | 6.92 M | - | 15.5 M | 9.88 M | 5.05 M | - | 16.2 M | 10.2 M | 5.53 M | - | 14.4 M | 9.35 M | 5.67 M | - | 11.4 M | 5.04 M | 3.36 M | - | 12.4 M | 7.75 M | 3.77 M | - | 12.3 M | 7.74 M | 4.31 M | - | 11.1 M | 7.76 M | 4.15 M | - | 9.9 M | 5.73 M | 2.24 M | - | 10.9 M | 5.76 M | 1.92 M | - | 9.06 M | 5.04 M | 2.72 M | - | 10.5 M | 6.54 M | 3.43 M | - | 7.86 M | 4.45 M | 2.76 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 16.2 M | 1.92 M | 7.39 M |
Operating Cash Flow of other stocks in the Medical instruments industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
20 K | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
1.02 B | $ 21.07 | 1.81 % | $ 10.7 B | USA |
 |
Becton, Dickinson and Company
BDX
|
3.33 B | $ 202.8 | -1.16 % | $ 58.3 B | USA |
 |
ICU Medical
ICUI
|
204 M | $ 151.86 | 0.14 % | $ 3.7 B | USA |
 |
iRhythm Technologies
IRTC
|
3.39 M | $ 180.4 | -4.68 % | $ 5.63 B | USA |
 |
Repro Med Systems
KRMD
|
-4.89 M | $ 5.67 | -2.41 % | $ 259 M | USA |
 |
Masimo Corporation
MASI
|
196 M | $ 140.04 | 1.54 % | $ 7.46 B | USA |
 |
Merit Medical Systems
MMSI
|
221 M | $ 86.37 | -7.31 % | $ 5.03 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
-9.85 M | $ 8.03 | -1.95 % | $ 162 M | USA |
 |
Alcon
ALC
|
1.34 B | $ 80.27 | -0.43 % | $ 40.4 B |  Schweiz |
 |
Predictive Oncology
POAI
|
-12.4 M | $ 6.83 | 1.08 % | $ 37.2 M | USA |
 |
AtriCure
ATRC
|
12.2 M | $ 41.66 | -1.76 % | $ 1.96 B | USA |
 |
electroCore
ECOR
|
-14.7 M | $ 5.62 | 11.73 % | $ 31 K | USA |
 |
Haemonetics Corporation
HAE
|
182 M | $ 82.2 | -2.19 % | $ 4.14 B | USA |
 |
AngioDynamics
ANGO
|
-10.1 M | $ 9.97 | -0.8 % | $ 407 M | USA |
 |
Harvard Bioscience
HBIO
|
14 M | $ 0.64 | -1.79 % | $ 27.1 M | USA |
 |
The Cooper Companies
COO
|
796 M | $ 83.71 | 0.69 % | $ 16.7 B | USA |
 |
LeMaitre Vascular
LMAT
|
44.1 M | $ 84.83 | -0.25 % | $ 1.9 B | USA |
 |
Glaukos Corporation
GKOS
|
-57.8 M | $ 113.09 | -0.93 % | $ 5.48 B | USA |
 |
InfuSystem Holdings
INFU
|
17.5 M | $ 8.61 | -4.01 % | $ 178 M | USA |
 |
Isoray
ISR
|
-18.3 M | - | 0.03 % | $ 108 M | USA |
 |
Nephros
NEPH
|
827 K | $ 4.89 | -2.5 % | $ 50.8 M | USA |
 |
Intuitive Surgical
ISRG
|
2.42 B | $ 587.18 | 0.36 % | $ 209 B | USA |
 |
Microbot Medical
MBOT
|
-8.53 M | $ 2.08 | -5.02 % | $ 21.2 M |  Israel |
 |
Milestone Scientific
MLSS
|
-2.92 M | $ 0.3 | 1.23 % | $ 23.9 M | USA |
 |
NeuroMetrix
NURO
|
-7.13 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
336 M | $ 23.57 | -0.23 % | $ 4.06 B | USA |
 |
OraSure Technologies
OSUR
|
27.4 M | $ 2.63 | -1.13 % | $ 196 M | USA |
 |
Pro-Dex
PDEX
|
-1.68 M | $ 41.51 | 0.51 % | $ 136 M | USA |
 |
Pulse Biosciences
PLSE
|
-33 M | $ 14.63 | -0.61 % | $ 703 M | USA |
 |
Repligen Corporation
RGEN
|
114 M | $ 166.85 | 0.26 % | $ 9.3 M | USA |
 |
ResMed
RMD
|
351 M | $ 252.15 | 0.49 % | $ 36.8 B | USA |
 |
BioLife Solutions
BLFS
|
8.43 M | $ 24.8 | -0.6 % | $ 1.14 B | USA |
 |
STERIS plc
STE
|
1.15 B | $ 258.0 | -1.03 % | $ 25.4 B | USA |
 |
Stereotaxis
STXS
|
-9.14 M | $ 2.53 | -2.13 % | $ 204 M | USA |
 |
Retractable Technologies
RVP
|
-11.6 M | $ 0.76 | -2.53 % | $ 22.8 M | USA |
 |
STAAR Surgical Company
STAA
|
15.7 M | $ 22.06 | -1.96 % | $ 1.08 B | USA |
 |
West Pharmaceutical Services
WST
|
653 M | $ 275.51 | 0.1 % | $ 20.1 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
461 M | $ 12.76 | 2.2 % | $ 2.59 B | USA |